July 25, 2014 7:08 PM ET


Company Overview of Afferon Corporation

Company Overview

Afferon Corporation operates as a pharmaceutical company. It engages in developing a vanilloid drug technology, which is used as a treatment for various indications, such as rhinitis, neuropathic pain, cluster headache, and vomiting. The company also offers resiniferatoxin, a therapy for the treatment of the symptoms of overactive bladder that includes urinary frequency, urgency, and incontinence. The company was incorporated in 1992 and is based in Wayne, Pennsylvania.

200 Eagle Road

Suite 200

Wayne, PA 19087

United States

Founded in 1992





Key Executives for Afferon Corporation

Chief Executive Officer and Director
Age: 72
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Traditional Medicinals, Inc. United States
ARTA Bioscience, Inc. United States
Macoven Pharmaceuticals, LLC United States
Zoetis Products LLC United States
Presutti Laboratories, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Afferon Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.